Age-Related Macular Degeneration

Age-Related Macular Degeneration

Agerelated macular degeneration (AMD) is a degenerative condition that usually appears after the age of 50 and occurs in the macula, the central region of the retina. This condition can affect central vision and has a progressive nature. There are two main types: dry type (geographic atrophy) and wet type (neovascular).

1. Symptoms:

  • Early symptoms may include blurry or distorted vision, loss or distortion in central vision, and changes in color perception.
  • It’s important to remember that AMD is progressive, so symptoms may worsen over time.

2. Risk Factors:

  • Age: More commonly seen in individuals aged 50 and above.
  • Genetic factors: Increased risk in individuals with a family history.
  • Systemic conditions such as smoking, high blood pressure, and high cholesterol.

3. Diagnosis:

  • Diagnosed by an eye doctor using an eye examination and imaging tests (optical coherence tomography, fluorescein angiography).

4. Treatment:

  • Treatment depends on the type of AMD:
    • Dry Type: There is no specific treatment for this type, but antioxidant and vitamin supplements may slow visual loss.
    • Wet Type: AntiVascular Endothelial Growth Factor (AntiVEGF) drugs are commonly used to treat wet type AMD. These drugs are injected into the eye and can inhibit abnormal blood vessel growth and reduce leakage.

5. Laser Treatment and Photodynamic Therapy:

  • In some cases, surgical interventions such as laser treatment or photodynamic therapy (PDT) may be used.

6. Lifestyle and Support:

  • Adopting a healthy lifestyle, not smoking, engaging in regular exercise, and maintaining a balanced diet can slow the progression of AMD.

    The treatment plan can vary depending on the patient’s condition, the type of AMD, and overall health status. Early diagnosis and treatment can help manage the progression of AMD and minimize vision loss. Therefore, regular eye examinations and consulting an eye doctor immediately upon noticing symptoms are crucial.